Name | 5-Bromo-2-chloro-3-ethoxypyridine |
---|
Molecular Formula | C7H7BrClNO |
---|---|
Molecular Weight | 236.49400 |
Exact Mass | 234.94000 |
PSA | 22.12000 |
LogP | 2.89620 |
HS Code | 2933399090 |
---|
~88% 1241752-29-3 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED; ARONOV, Alex; COME, Jon, H.; DAVIES, Robert, J.; PIERCE, Albert, C.; WANG, Jian; NANTHAKUMAR, Suganthini; CAO, Jingrong; BANDARAGE, Upul, K.; KRUEGER, Elaine; TIRAN, Amaud, Le; LIAO, Yusheng; MESSERSMITH, David; COLLIER, Philip, N.; GREY, Ronald; O'DOWD, Hardwin; HENDERSON, James, A.; GRILLOT, Anne-Laure Patent: WO2011/87776 A1, 2011 ; Location in patent: Page/Page column 49; 51 ; WO 2011/087776 A1 |
~% 1241752-29-3 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED; ARONOV, Alex; COME, Jon, H.; DAVIES, Robert, J.; PIERCE, Albert, C.; WANG, Jian; NANTHAKUMAR, Suganthini; CAO, Jingrong; BANDARAGE, Upul, K.; KRUEGER, Elaine; TIRAN, Amaud, Le; LIAO, Yusheng; MESSERSMITH, David; COLLIER, Philip, N.; GREY, Ronald; O'DOWD, Hardwin; HENDERSON, James, A.; GRILLOT, Anne-Laure Patent: WO2011/87776 A1, 2011 ; WO 2011/087776 A1 |
~% 1241752-29-3 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED; ARONOV, Alex; COME, Jon, H.; DAVIES, Robert, J.; PIERCE, Albert, C.; WANG, Jian; NANTHAKUMAR, Suganthini; CAO, Jingrong; BANDARAGE, Upul, K.; KRUEGER, Elaine; TIRAN, Amaud, Le; LIAO, Yusheng; MESSERSMITH, David; COLLIER, Philip, N.; GREY, Ronald; O'DOWD, Hardwin; HENDERSON, James, A.; GRILLOT, Anne-Laure Patent: WO2011/87776 A1, 2011 ; WO 2011/087776 A1 |
~% 1241752-29-3 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED; ARONOV, Alex; COME, Jon, H.; DAVIES, Robert, J.; PIERCE, Albert, C.; WANG, Jian; NANTHAKUMAR, Suganthini; CAO, Jingrong; BANDARAGE, Upul, K.; KRUEGER, Elaine; TIRAN, Amaud, Le; LIAO, Yusheng; MESSERSMITH, David; COLLIER, Philip, N.; GREY, Ronald; O'DOWD, Hardwin; HENDERSON, James, A.; GRILLOT, Anne-Laure Patent: WO2011/87776 A1, 2011 ; WO 2011/087776 A1 |
Precursor 4 | |
---|---|
DownStream 1 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |